Publicaciones en colaboración con investigadores/as de Leiden University Medical Center (9)

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

    Molecular Therapy Nucleic Acids, Vol. 34

2017

  1. Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 2, pp. 312-322

2016

  1. The urgent need to recover MHC class I in cancers for effective immunotherapy

    Current Opinion in Immunology, Vol. 39, pp. 44-51

2010

  1. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: A meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four european populations

    Arthritis and Rheumatism, Vol. 62, Núm. 5, pp. 1236-1245

2005

  1. Analysis of a Functional BTNL2 Polymorphism in Type 1 Diabetes, Rheumatoid Arthritis, and Systemic Lupus Erythematosus

    Human Immunology, Vol. 66, Núm. 12, pp. 1235-1241

2002

  1. Genetic determinants of rheumatoid arthritis: The inducible nitric oxide synthase (NOS2) gene promoter polymorphism

    Genes and Immunity, Vol. 3, Núm. 5, pp. 299-301

2001

  1. Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition

    Arthritis and Rheumatism, Vol. 44, Núm. 2, pp. 307-314